TB

Publications

click to view chapters and sections

Disease Control Priorities in Developing Countries (2nd Edition)

1. 1. Investing in Health
   1. Annex 1.A: The Burden of Disease in 2001
2. 2. Intervention Cost–Effectiveness: Overview of Main Messages
   1. Discussion
3. 4. Priorities for Global Research and Development of Interventions
4. 6. Product Development Priorities
   1. Introduction
   2. Diagnostics
   3. Financing and Institutional Arrangements for New Product Development
   4. Regulatory and Liability Issues
5. 8. Improving the Health of Populations: Lessons of Experience
   1. Cases
6. 9. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?
   1. Costing and Financing Additional Spending for the MDGs
7. 12. Financing Health Systems in the 21st Century
   1. Health Financing Systems
   2. Health Financing Issues in LICs
8. 13. Recent Trends and Innovations in Development Assistance for Health
   1. Making Development Assistance for Health More Effective: Lessons Learned
   2. Conclusions
9. 16. Tuberculosis
   1. Tuberculosis Infection, Disease, and Death
   2. Epidemiological Burden and Trends
   3. Interventions against Tuberculosis
   4. Alternative and Complementary Approaches to the Diagnosis and Treatment of Active Disease
   5. Cost-Effectiveness of Interventions against Tuberculosis
   6. Cost-Effectiveness of Managing Endemic Tuberculosis
   7. Cost-Effectiveness of Managing Tuberculosis Outbreaks
   8. Summary of Cost-Effectiveness Analyses
   9. Research and Development
   10. Conclusions
   11. Acknowledgments
10. 20. Vaccine–Preventable Diseases
    1. Improving the Costs and Cost-Effectiveness of Immunization Programs
11. 35. Respiratory Diseases of Adults
    1. Acute Diseases: Pneumonia and Influenza
    2. Chronic Respiratory Diseases: Nature, Causes, and Burden
    3. Occupational Lung Disease and Other Respiratory Diseases
    4. General Approach to Lowering Risk of Adult Respiratory Disease
    5. Future Research Needs
12. 55. Drug Resistance
    1. Risk Factors
    2. Interventions
    3. Implementation of Strategies: Two Lessons from Experience
    4. Agenda for Action
13. 60. Occupational Health
    1. Nature and Causes of Occupational Health Conditions in the Developing World
14. 62. Control and Eradication
15. 72. Ensuring Supplies of Appropriate Drugs and Vaccines
    1. Selection of Drugs
    2. Procurement of Drugs
    3. The WHO Prequalification Schemes
    4. Issues for the Future
    5. Vaccine Research Priorities

Global Burden of Disease and Risk Factors

1. 3. The Burden of Disease and Mortality by Condition: Data, Methods, and Results for 2001
   1. Global and Regional Mortality in 2001
   2. Discussion and Conclusions

Priorities in Health

1. 1. Accomplishments, Challenges, and Priorities
2. 2. Success in Addressing Priorities
3. 4. Cost–Effective Strategies for the Excess Burden of Disease in Developing Countries
4. 5. Cost–Effective Strategies for Noncommunicable Diseases, Risk Factors, and Behaviors
   1. Tobacco Use
5. 6. Providing Interventions
6. 7. Pillars of the Health System
   1. Management of Health Services
   2. Human Resources
   3. Financing

Chapter Presentations

Chapter 02. Intervention Cost-Effectiveness: Overview of Main Messages

1. Cost-effectiveness of Interventions for Epidemic Tuberculosis in Low- and Middle-Income Countries
2. Cost-effectiveness of Interventions for Endemic Tuberculosis in Low- and Middle-Income Countries
3. Neglected Low-Cost Opportunities in South Asia: HIV/AIDS and Tuberculosis

Chapter 06. Product Development Priorities

1. Product Development for HIV/AIDS and TB, Public-Private Partnerships, 2004

Chapter 09. Millennium Development Goals for Health: What Will It Take to Accelerate Progress?

1. Effective Interventions to Achieve the Tuberculosis MDG